NM_000492.4:c.355A>G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2
The NM_000492.4(CFTR):c.355A>G(p.Ile119Val) variant causes a missense change. The variant allele was found at a frequency of 0.000107 in 1,607,930 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000492.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.355A>G | p.Ile119Val | missense_variant | Exon 4 of 27 | ENST00000003084.11 | NP_000483.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250942Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135600
GnomAD4 exome AF: 0.000114 AC: 166AN: 1455738Hom.: 0 Cov.: 31 AF XY: 0.000105 AC XY: 76AN XY: 724480
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74342
ClinVar
Submissions by phenotype
Cystic fibrosis Uncertain:3
- -
This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 119 of the CFTR protein (p.Ile119Val). This variant is present in population databases (rs193922518, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with CFTR-related conditions. ClinVar contains an entry for this variant (Variation ID: 35870). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
The p.I119V variant (also known as c.355A>G), located in coding exon 4 of the CFTR gene, results from an A to G substitution at nucleotide position 355. The isoleucine at codon 119 is replaced by valine, an amino acid with highly similar properties. This variant was identified in one asymptomatic carrier with p.F508del in trans (Claustres M et al. Hum. Mutat., 2017 10;38:1297-1315). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on available evidence to date, the clinical significance of this alteration remains unclear. -
CFTR-related disorder Uncertain:2
- -
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
not provided Uncertain:2
The I119V variant in the CFTR gene has not been reported previously in the medical literature as a pathogenic variant, nor as a benign variant, to our knowledge. However, the I119V variant is reported as likely pathogenic in ClinVar by a different clinical laboratory, but additional evidence is not available (ClinVar SCV000052177.1; Landrum et al., 2016). The I119V variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The I119V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved in mammals, however, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Missense variants in nearby residues (N113I, E116K, E116Q, R117G, R117C, R117L, R117P, A120T, Y122H, Y122C) have been reported in the Human Gene Mutation Database in association with CFTR-related disorders (Stenson et al., 2014), supporting the functional importance of this region of the protein. We interpret I119V as a variant of uncertain significance. -
The CFTR c.355A>G; p.Ile119Val variant (rs193922518), is reported in a large COPD cohort but without clear disease association (Saferali 2022). This variant has also been reported in the Cystic Fibrosis Mutation Database in an individual with probable CF, but a second variant was not identified (see link). This variant is reported in ClinVar (Variation ID: 35870), and is found in the general population with an overall allele frequency of 0.003% (8/282,340 alleles) in the Genome Aggregation Database. Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.611). Due to limited information, the clinical significance of this variant is uncertain at this time. REFERENCES Cystic Fibrosis Mutation Database: http://www.genet.sickkids.on.ca/cftr/MutationDetailPage.external?sp=1231 Saferali A et al. CFTR variants are associated with chronic bronchitis in smokers. Eur Respir J. 2022 Aug 10;60(2):2101994. PMID: 34996830. -
not specified Uncertain:1
Variant summary: CFTR c.355A>G (p.Ile119Val) results in a conservative amino acid change located in the ABC transporter type 1, transmembrane domain of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.8e-05 in 250942 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.355A>G in individuals affected with Cystic Fibrosis and no experimental evidence demonstrating its impact on protein function have been reported in the literature. CFTR-France database reports one asymptomatic patient that is compound heterozygote for the variant and p.F508del, a CF-causing variant (listed in Claustres_2017). The Sick Kids Cystic Fibrosis Mutation Database reports that the variant was found in a (probable) CF patient whose other variant is as yet unidentified; patient is reported with recurrent chest infections but normal sweat tests. More recently, this variant has been reported as being observed in one allele within the COPDGene study, an observational study of current and former smokers (example, Saferali_2022). These reports do not provide unequivocal conclusions about association of the variant with Cystic Fibrosis/CFTR-related disorders. The following publications have been ascertained in the context of this evaluation (PMID: 28603918, 34996830). ClinVar contains an entry for this variant (Variation ID: 35870). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at